Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $42.2 million.

  • Integra Lifesciences Holdings' Other Non-Current Assets fell 2179.06% to $42.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.2 million, marking a year-over-year decrease of 2179.06%. This contributed to the annual value of $66.5 million for FY2024, which is 1429.87% up from last year.
  • Per Integra Lifesciences Holdings' latest filing, its Other Non-Current Assets stood at $42.2 million for Q3 2025, which was down 2179.06% from $46.2 million recorded in Q2 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' Other Non-Current Assets peaked at $77.9 million during Q3 2023, and registered a low of $16.4 million during Q4 2021.
  • For the 5-year period, Integra Lifesciences Holdings' Other Non-Current Assets averaged around $51.4 million, with its median value being $54.0 million (2024).
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 8985.84% in 2021, then surged by 24787.1% in 2022.
  • Integra Lifesciences Holdings' Other Non-Current Assets (Quarter) stood at $16.4 million in 2021, then skyrocketed by 247.87% to $57.2 million in 2022, then increased by 1.76% to $58.2 million in 2023, then increased by 14.3% to $66.5 million in 2024, then plummeted by 36.49% to $42.2 million in 2025.
  • Its Other Non-Current Assets stands at $42.2 million for Q3 2025, versus $46.2 million for Q2 2025 and $53.2 million for Q1 2025.